ADVERTISEMENT
ADVERTISEMENT
Teva, Mylan Back Plan For New Bellwether In Price-Fix MDL
Law360 (March 2, 2021, 6:53 PM EST) -- Mylan, Teva and Par Pharmaceuticals are among a group of generic-drug makers that told a Pennsylvania federal judge Monday they're fine with her plan to swap out a bellwether case in multidistrict litigation that accuses most of the generics industry of price-fixing.
The companies told U.S. District Judge Cynthia M. Rufe they share her inclination for scrapping the planned bellwether trial in a case brought by various state attorneys general that centers around Teva. Instead, the companies want Judge Rufe to select another case — one that focuses on Heritage Pharmaceuticals, which the court mentioned as a possibility less than a...